Navigation Links
Midwest Healthcare Startups Raise $996 Million in 2012
Date:1/7/2013

CLEVELAND, Jan. 7, 2013 /PRNewswire/ -- Midwest healthcare companies attracted $996 million in new investments across 182 companies in 2012 according to the BioEnterprise Midwest Healthcare Venture Investment Report.  The total dollars attracted is up by twenty-three percent from 2011. Ohio ($292 million), Minnesota ($165 million), and Illinois ($146 million) led Midwestern states in attracting investment dollars; Cleveland, Minneapolis, and Chicago were the leaders among Midwest regions.

(Logo:  http://photos.prnewswire.com/prnh/20101028/DC90488LOGO )

"Investment activity in Midwest healthcare deals continues its upward trend, outperforming previous years' activity for 3 years in a row.
As with the rest of the country, Midwest healthcare investing fell dramatically in 2009 after strong years in 2007 and 2008, but it appears investors are again optimistic about Midwest deals. 2013 should be an interesting year to watch," said Aram Nerpouni, Interim President of BioEnterprise, the Cleveland biomedical accelerator.

By sector, the 2012 equity funding was allocated as follows:

  • Medical device companies:  $309 million (32%)
  • Healthcare IT and service companies: $177 million (18%)
  • Biopharmaceutical companies: $487 million (50%)
  • "The Midwest typically sees more medical device companies than either healthcare IT or biopharmaceutical; however, biotech saw the largest influx of dollars in 2012 as investors continue to focus on  later stage biotech opportunities," said Nerpouni.  "Investment activity in Midwest healthcare IT remains robust as investors are drawn by payers and providers searching for applications to improve patient outcomes and efficiencies."

    The Midwest Healthcare Venture Investment Report includes all reported numbers and regionally collected data. For complete state and region results across the Midwest, see the attached table. To view additional data about Midwest healthcare business activity visit www.bioenterprise.com/Reports/.

    Table:  Midwest Healthcare Venture Investment (By State)State20122011201020092008$ Millions# of Cos.$ Millions# of Cos.$ Millions# of Cos.$ Millions# of Cos.$ Millions# of Cos.Illinois146.2

    10

    44.2

    9

    160.9

    11

    38.9

    8

    97.3

    13Indiana64.7

    11

    14.1

    9

    25.05

    16

    76.3

    14

    75.4

    7Iowa-

    -

    -

    -

    7.3

    1

    36.8

    3

    4.0

    1Kansas-

    -

    18.5

    2

    14.5

    13

    4.3

    5

    16.9

    9Kentucky33.8

    4

    11.5

    7

    11.4

    4

    97.3

    7

    19.2

    6Michigan107.1

    16

    30.8

    16

    76.3

    12

    102.2

    14

    105.0

    12Minnesota164.7

    17

    223.3

    24

    138.7

    20

    199.0

    23

    318.9

    22Missouri57.2

    6

    168.7

    9

    19.9

    9

    65.8

    8

    50.2

    11Ohio291.7

    70

    177.8

    67

    147.2

    47

    105.4

    40

    189.1

    43Western Pennsylvania 81.5

    37

    67.0

    25

    86.2

    20

    37.8

    24

    126.2

    33Wisconsin48.8

    11

    53.8

    9

    51.3

    9

    16.2

    10

    48.5

    8Total995.7182809.7177738.8162780.01561,050.7165Table:  Midwest Healthcare Venture Investment (By Region)*Region20122011201020092008$ Millions# of Cos.$  Millions# of Cos.$  Millions# of Cos.$ Millions# of Cos.$
    Millions# of Cos.Chicago146.2

    9

    44.2

    9

    160.9

    11

    38.9

    8

    97.3

    13Indianapolis64.7

    10

    11.5

    7

    18.5

    9

    41.2

    9

    73.0

    6Louisville7.9

    3

    11.4

    6

    11.4

    4

    2.5

    4

    13.4

    3Detroit-Ann Arbor107.1

    15

    23.0

    10

    46.5

    8

    68.8

    7

    89.0

    8SW Michigan-

    -

    7.8

    6

    29.8

    4

    14.5

    5

    16.0

    2Minneapolis162.4

    15

    223.3

    24

    138.7

    20

    199.0

    23

    318.9

    22St. Louis57.2

    6

    112.7

    8

    18.9

    9

    27.8

    7

    47.2

    10Kansas City*-

    -

    18.5

    2

    15.4

    13

    42.3

    6

    19.9

    10Cincinnati*77.3

    12

    37.3

    6

    8.5

    4

    121.2

    8

    19.2

    2Cleveland226.5

    43

    124.7

    40

    135.1

    33

    66.3

    21

    163.5

    31Columbus13.3

    11

    15.1

    19

    3.1

    5

    12.4

    13

    6.4

    10Pittsburgh81.5

    37

    67.0

    25

    86.2

    20

    37.8

    24

    126.2

    33Wisconsin48.8

    11

    53.8

    9

    51.3

    9

    16.2

    10

    48.5

    8* Border MSAs such as Kansas City and Cincinnati include deals from both states in those geographies; deals are aggregated into state totals based on the MSA's principal state

    **Regions' totals do not equal states as not all areas are included in list of regions

    Sources: Compiled by BioEnterprise from Venture Wire, Private Equity Week, Wall Street Journal, Venture Source, SEC Filings, company press releases, www.biospace.com, and Midwest bioscience organizations and institutions.

    About BioEnterpriseBioEnterprise is a business formation, recruitment, and acceleration effort designed to support the growth of bioscience companies. Located in Cleveland, BioEnterprise provides management counsel and support services to healthcare companies. BioEnterprise partners are Case Western Reserve University, Cleveland Clinic, University Hospitals, Summa Health System, and the Austen BioInnovation Institute in Akron. Additional technology partners include the NASA Glenn Research Center, Cleveland State University, NorTech, and BioOhio.

    The initiative comprises the collective activities of BioEnterprise and its partners' commercialization offices:  the Case Office of Technology Transfer, Cleveland Clinic Innovations, University Hospitals Case Medical Center - Center for Clinical Research and Summa Enterprise Group.  The combined efforts of these groups has created, recruited, and accelerated more than 130 companies in ten years.


    '/>"/>
    SOURCE BioEnterprise Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Related biology technology :

    1. Genetics Policy Institute (GPI) Collaborates on Second Midwest Conference on Stem Cell Biology and Therapy, Oct. 5-7 at Oakland University
    2. BioSpace Spotlights the growing Midwest Life Science Community
    3. Karmanos Cancer Center first in Midwest to offer latest Molecular Breast Imaging
    4. Sequenom Announces Participation at the Lazard Capital Markets 8th Annual Healthcare Conference
    5. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
    6. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
    7. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
    8. Sequenom Announces Participation at the 23rd Annual Piper Jaffray Healthcare Conference
    9. SuperNova Diagnostics® to Present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City
    10. diaDexus, Inc. to Present at the Canaccord Genuity Healthcare Conference
    11. ViroPharma to Participate in Two December Healthcare Investor Conferences
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2017)... Feb. 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: ... on Friday, February 24, 2017 a total of 10,672,750 common ... $0.13 per common share. Proceeds from the exercise of these ... InMed,s Treasury.   ... "We are grateful for this expression of confidence by ...
    (Date:2/27/2017)... February 27, 2017 Four US ... evaluation today, and they are: Anthera Pharmaceuticals Inc. (NASDAQ: ... California Inc. (NASDAQ: PACB), and Conatus Pharmaceuticals Inc. (NASDAQ: ... ETF Trends, market observers are growing more bullish on ... enact reforms to free cash held overseas for tax ...
    (Date:2/27/2017)... FRANCISCO , Feb. 27, 2017 Fluxion ... Spain has been appointed as a ... System. The IsoFlux system will be used in Genetracer ... relevant to lung and colon cancer, with plans to ... The laboratory is utilizing Fluxion,s IsoFlux System to isolate, ...
    (Date:2/27/2017)... ... February 27, 2017 , ... The Catalyst Midwest ... in the Midwest offering premix services and private label organic services. , The first ... according Jos Zamzow, chief operating officer of Dynamite Marketing, which owns the facility. , ...
    Breaking Biology Technology:
    (Date:2/2/2017)... Fla. , Feb. 2, 2017   ... a clinical-stage immuno-oncology company specializing in the development ... for the treatment of cancer and metastatic disease, ... scale-up and GMP manufacturing of a second clinical ... vaccine targeting folate receptor alpha. The manufactured vaccine ...
    (Date:2/1/2017)... February 1, 2017 IDTechEx Research, a leading ... technology, announces the availability of a new report, Sensors for ... Continue Reading ... ... collaborative robots. Source: IDTechEx Report "Sensors for Robotics: Technologies, Markets and ...
    (Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
    Breaking Biology News(10 mins):